Qbic Fund
Venture capitalSt-Denijs-Westrem · Pre-Seed–Series A · 18 people tracked
Find your way into Qbic Fund
1,568 people in our graph share verified history with the Qbic Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Qbic is a seed and early-stage venture capital fund built around an inter-university model. It backs spin-offs and start-ups that valorize research originating at its knowledge partners — partner universities, research institutes and hospitals. Eligible companies are either knowledge-partner spin-offs founded on technological innovations from those institutions, or start-ups with a strong R&D collaboration with a knowledge partner structured through joint development contracts, clinical studies or IP license agreements. The fund concentrates on deep-technology and life-science innovation, aiming to transform scientific breakthroughs into commercially viable, sustainable ventures across areas such as biotech, therapeutics, photonics, energy and other advanced technologies.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & public directoriesWhat they invest in
from 13 of 26 portfolio companiesBiotech ×7Medical Devices ×7Healthtech ×6Deep Tech ×5Digital Health ×4AI & Machine Learning ×3AgTech ×2Data & Infrastructure ×2
HQs:Belgium×10
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×42 founders×24+ founders×2
What their founders studiedfrom 10 founders with field-of-study data
Engineering ×3Life Sciences ×3Business & Management ×2Medicine ×2
Where their founders worked beforefrom 11 founders with career history
Bio Base Europe Pilot Plant ×3Artesis Hogeschool Antwerpen ×2DASH7 Alliance ×2Ghent University ×2VIB ×2
Investments · 26 tracked
founders shown can be your intro pathObulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGhent, BE
Yves Briers(Scientific Founder)in
Co-investorsBoehringer Ingelheim Venture Fund
Aloxy develops industrial IoT solutions including sensors, gateways, and middleware for the chemical, oil and gas, and process industries.
Advanced ManufacturingDeep TechEnterprise SoftwareHardwareIoTAntwerp, BE
Maarten WeyninGlenn Ergeertsin
Co-investorsDow Venture CapitalInnovation Fund sa/nv
AmphiStar develops biosurfactants through advanced bioprocessing and fermentation for industrial applications including chemicals and consumer goods.
AgTechBiotechCircular EconomyCleantechClimate TechNew MaterialsGhent, BE
Sophie Roelants(Co-founder & COO)inBernd Everaert(Co-founder & Executive Director)inKarolien Maes(Co-founder and Head of Bioprocessing and Scale Up)inSofie De Maeseneire(Co-founder and Head of Synthetic Biology)Pierre-Franck Valentin(CEO)inWim Allegaert(CFO)in
Co-investorsEuropean Circular Bioeconomy FundPMV
Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.
AgTechBiotechDeep TechHealthtechGhent, BE
Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in
Co-investorsAgri Investment FundSeventure PartnersPMVV-Bio Ventures
Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsimec.xpandKurma PartnersWhite FundWallonie Entreprendre
Cascador Health provides real-world data analytics and clinical research services to pharmaceutical companies and healthcare organizations, focusing on market access, clinical evidence generation, and therapy adoption in healthcare.
BiotechData & InfrastructureDigital HealthHealthtechMedical Devices
Philip Taillieu(Founder & CEO)
Co-investorsPMVVolta Ventures
TrustDriven provides integrated software products for nonprofits and membership organizations, including fundraising, volunteer management, membership administration, and advocacy tools.
Enterprise SoftwareImpact & Social GoodSaaS
Co-investorsWaterloo Accelerator CentreAndreessen HorowitzBHP VenturesBreakthrough Energy VenturesEarthshot VenturesEntourage Ventures+6 more
Innocens develops an on-premise data platform for hospitals that collects, synchronizes, and annotates high-frequency time-series medical data from clinical devices, designed specifically for neonatal ICU applications.
AI & Machine LearningData & InfrastructureDigital HealthMedical DevicesBrussels, BE
David Van Laere(Founder)in
moveUP provides digital platforms for healthcare delivery, offering patient engagement programs, healthcare professional collaboration tools, and real-world data collection across specialties including orthopedics, bariatrics, oncology, and cardiology.
Digital HealthHealthtechSaaS
Co-investorsImpact Expansion Management SarlKaristaNina CapitalNovaCapital
MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.
BiotechHealthtechMedical DevicesGhent, BE
THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments.
AI & Machine LearningBiotechMedical DevicesLiège, BE
Francesca Rapino(CEO)inPierre Close(CSO)in
Co-investorsWallonie Entreprendre
Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation.
BiotechDeep TechMedical DevicesGent, BE
Philip
Co-investorsNovalis Biotech
Ultra-low power, ultra-low latency 3D perception sensors for extended reality.
Co-investorsCapricorn Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AILOSBlue FooteyeoFlindrFlindr TherapeuticsPleeviRainbow CropsSighteraSpica TherapeuticsSwaveTanai TherapeuticsWeavely
Portfolio news
latest coverage across their companiesCascador · techcabal.com · Sep 7, 2026

Innocens · thesaasnews.com · Aug 11, 2026
Driven · theaiinsider.tech · Aug 5, 2026
Aloxy · electramining.co.za · Jul 21, 2026
Trince · natlawreview.com · Jan 22, 2026
MRM Health · pharmaceutical-technology.com · Sep 5, 2025
AmphiStar · biotope-ventures.com · Jul 17, 2025
Frequently asked questions
- How many investments has Qbic Fund made?
- Qbic Fund has 26 tracked investments, including 1 dated in the last 24 months.
- What stage does Qbic Fund invest at?
- Qbic Fund invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Qbic Fund focus on?
- Qbic Fund focuses on Advanced Manufacturing, AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Crypto & Web3, Deep Tech, Digital Health, Energy, FoodTech, Hardware, Healthtech, IoT, Medical Devices, Mobility & Transportation, New Materials, Quantum Computing, SaaS, Sector Agnostic, Semiconductors, Space Tech.
- Where is Qbic Fund located?
- Qbic Fund is headquartered in St-Denijs-Westrem, BE.
- Does Qbic Fund lead rounds?
- Qbic Fund typically participates in rounds rather than leading them.
- Who does Qbic Fund co-invest with?
- Qbic Fund most often shares deals with PMV, Capricorn Venture Partners, Kurma Partners, among 16 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
MPG Fund is an early-stage venture investor backing technology startups.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.
















































